C000221226 Holdings — BlackRock Future Health ETF
All 52 reported holdings of BlackRock Future Health ETF (C000221226) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Johnson & Johnson | 7.88% | $795.05K |
| Gilead Sciences Inc | 5.40% | $544.95K |
| Edwards Lifesciences Corp | 4.74% | $478.12K |
| Amgen Inc | 4.60% | $464.67K |
| Blackrock Cash Funds Treasury Sl Agency Shares | 4.36% | $440.00K |
| Merck & Co Inc | 3.92% | $395.23K |
| Biogen Inc | 3.63% | $366.26K |
| Wuxi Biologics Cayman Inc | 3.22% | $324.73K |
| Waters Corp | 3.17% | $320.05K |
| Mettler-Toledo International Inc | 3.10% | $312.77K |
| Intuitive Surgical Inc | 2.95% | $297.90K |
| Charles River Laboratories International Inc | 2.95% | $297.71K |
| Vertex Pharmaceuticals Inc | 2.92% | $294.89K |
| Argenx SE | 2.85% | $287.67K |
| Moderna Inc | 2.64% | $266.64K |
| Pfizer Inc | 2.48% | $250.79K |
| Danaher Corp | 2.48% | $250.17K |
| Bruker Corp | 2.32% | $234.54K |
| Novartis AG | 2.31% | $233.36K |
| Bio-Techne Corp | 2.09% | $210.49K |
| Dexcom Inc | 2.06% | $208.01K |
| Gsk PLC | 2.03% | $205.37K |
| Protagonist Therapeutics Inc | 1.99% | $201.01K |
| Thermo Fisher Scientific Inc | 1.94% | $195.42K |
| Roche Holding AG | 1.80% | $181.74K |
| Insmed Inc | 1.79% | $180.77K |
| AstraZeneca PLC | 1.62% | $163.95K |
| Ucb SA | 1.58% | $159.56K |
| Cogent Biosciences Inc | 1.56% | $157.23K |
| Incyte Corp | 1.55% | $156.72K |
| IDEXX Laboratories Inc | 1.42% | $143.56K |
| Boston Scientific Corp | 1.39% | $140.28K |
| Bristol-Myers Squibb Co | 1.30% | $131.42K |
| BioMarin Pharmaceutical Inc | 1.22% | $122.91K |
| Teva Pharmaceutical Industries Ltd | 1.18% | $118.75K |
| Revolution Medicines Inc | 1.03% | $104.20K |
| Alcon AG | 1.01% | $101.82K |
| Summit Therapeutics Inc | 0.75% | $75.26K |
| Medline Inc | 0.64% | $64.88K |
| Dianthus Therapeutics Inc | 0.57% | $57.16K |
| BioNTech SE | 0.52% | $52.45K |
| Apogee Therapeutics Inc | 0.47% | $47.74K |
| BlackRock Funds III | 0.25% | $25.64K |
| Sagimet Biosciences Inc | 0.13% | $13.55K |
| Erasca Inc | 0.13% | $13.32K |
| Eikon Therapeutics Inc | 0.12% | $12.05K |
| Ultragenyx Pharmaceutical Inc | 0.11% | $11.36K |
| Contra Abiomed, Inc. | 0.00% | $371 |
| Contra Mirati Therapeu | 0.00% | $264 |
| Contra Blueprint Medic | 0.00% | $110 |
| Contra Vigil Neuroscie | 0.00% | $24 |
| Contra Frequency Thera | 0.00% | $0 |
C000221226 overview: performance, fees, allocation and SEC filings